These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7689178)

  • 21. Structural and functional analysis of botulinum neurotoxin subunits for pH-dependent membrane channel formation and translocation.
    Chellappan G; Kumar R; Santos E; Goyal D; Cai S; Singh BR
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1510-6. PubMed ID: 26012869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocytosis of Clostridium botulinum type B neurotoxin into rat brain synaptosomes.
    Kohda T; Kamata Y; Kozaki S
    J Vet Med Sci; 2000 Nov; 62(11):1133-8. PubMed ID: 11129854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Structure and function of botulinum toxin].
    Fujii N
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell entry strategy of clostridial neurotoxins.
    Binz T; Rummel A
    J Neurochem; 2009 Jun; 109(6):1584-95. PubMed ID: 19457120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
    Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
    Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between Clostridium botulinum neurotoxin and gangliosides.
    Kitamura M; Iwamori M; Nagai Y
    Biochim Biophys Acta; 1980 Mar; 628(3):328-35. PubMed ID: 6768400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y; Singh BR
    Protein Expr Purif; 2004 Mar; 34(1):8-16. PubMed ID: 14766296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
    J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR; Marvaud JC; Raffestin S
    Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mode of action and effects of botulinum neurotoxin A].
    Périé S; Lacau St-Guily J
    Ann Otolaryngol Chir Cervicofac; 1996; 113(2):73-8. PubMed ID: 8999747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and biological activity of botulinum neurotoxin.
    DasGupta BR
    J Physiol (Paris); 1990; 84(3):220-8. PubMed ID: 2074545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR; Barbieri JT
    Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Botulinum neurotoxin].
    Poulain B
    Rev Neurol (Paris); 2010 Jan; 166(1):7-20. PubMed ID: 19846187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.
    Dekleva ML; DasGupta BR
    Biochem Biophys Res Commun; 1989 Jul; 162(2):767-72. PubMed ID: 2667520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis.
    Bandyopadhyay S; Clark AW; DasGupta BR; Sathyamoorthy V
    J Biol Chem; 1987 Feb; 262(6):2660-3. PubMed ID: 3029090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of ion channels in lipid bilayers by a peptide with the predicted transmembrane sequence of botulinum neurotoxin A.
    Oblatt-Montal M; Yamazaki M; Nelson R; Montal M
    Protein Sci; 1995 Aug; 4(8):1490-7. PubMed ID: 8520474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal.
    Neale EA; Bowers LM; Jia M; Bateman KE; Williamson LC
    J Cell Biol; 1999 Dec; 147(6):1249-60. PubMed ID: 10601338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes.
    Hoch DH; Romero-Mira M; Ehrlich BE; Finkelstein A; DasGupta BR; Simpson LL
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1692-6. PubMed ID: 3856850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
    Kroken AR; Blum FC; Zuverink M; Barbieri JT
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D.
    Tsukamoto K; Kozai Y; Ihara H; Kohda T; Mukamoto M; Tsuji T; Kozaki S
    Microb Pathog; 2008 Jun; 44(6):484-93. PubMed ID: 18242046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.